Olesen Value Fund sells $716,664 of Solitron Devices stock

Olesen Value Fund sells $716,664 of Solitron Devices stock

Olesen Value Fund sells $716,664 of Solitron Devices stock
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with…
Key takeaway: At least one financial services trade group, Americas Credit Unions, has declared its support for increasing the size standard that helps define small businesses. Forward Look: The SBA has extended the comment period on the proposed change to Nov. 20. Supporting data: The agency has already received more than 3,000 comment letters. Businesses,…
Tech investors keep seeing and hearing the same headlines about tech companies making their own chips and diversifying away from Nvidia (NVDA -4.97%)‘s high-priced products. Initially, it’s easy to see why such a scenario may appear to be a troubling one, given that tech giants have the resources to invest in their own chipmaking abilities….
Key Points Shares of Broadcom (NASDAQ: AVGO) climbed on Tuesday, gaining as much as 4.1%. As of 2:46 p.m. ET, the stock was still up 3.1%. The catalyst that sent the semiconductor specialist higher was a report that Intel plans to raise prices for its CPUs. Missed Nvidia in 2009? This Rare Signal Is Flashing…
As conversations among financial advisors increasingly focus on volatility and whether the market is in an artificial intelligence bubble, executives at Vanguard have some reassuring news. The company forecasts 2.3% U.S. GDP growth in 2026 and 3% growth in 2027, largely driven by the continued evolution and investment in AI technology. Vanguard researchers estimate that…
First and only CAVT device for stroke demonstrated high revascularization rates, short procedure times and low complication rates ALAMEDA, Calif., July 22, 2026 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), the world’s leading thrombectomy company, announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLTâ„¢, the company’s novel computer assisted vacuum…